BRAF and melanoma: Although BRAF-mutant drug-sensitive melanomas show increased apoptosis in response to BRAF or BRAF/MEK inhibition in vitro and in vivo, a sufficient number of cells frequently remains to allow the outgrowth of resistant melanomas at their original site14,35.